For the year ending 2025-12-31, RVRC had -$1,590K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -13,449 |
| Depreciation | 6 |
| Stock based compensation | 624 |
| Change in deferred tax liability, net | 358 |
| Intangible asset and goodwill impairment expenses | 9,684 |
| Reduction in the carrying amount of operating lease right of use asset | 7 |
| Finance expense (income) | -3 |
| Operating lease liability | -7 |
| Other current assets | 137 |
| Other account payables | 359 |
| Accounts payable | 21 |
| Net cash used in operating activities | -2,531 |
| Deposit for operating right of use assets | 18 |
| Withdrawal from (investment in) short term deposit | -975 |
| Investment in restricted deposit | 9 |
| Purchase of property, plant and equipment | 7 |
| Net cash provided by investing activities | 941 |
| Increase (decrease) in cash and cash equivalents | -1,590 |
| Cash and cash equivalents at the beginning of period | 3,268 |
| Cash and cash equivalents at the end of period | 1,678 |
Revium Rx. (RVRC)
Revium Rx. (RVRC)